Phio Pharmaceuticals Corp. (PHIO) Reports Q2 Loss of $1.47

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q2 EPS of ($1.47).

For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade
• Redburn upgrades Southwest, stays bullish on Delta and United